Anshul Life Sciences 
Dealstreet

SAM, AZB act on acquisition of Anshul Life Sciences by Barentz

Dutch company Barentz has acquired Anshul Life Sciences.

Bar & Bench

Barentz has made an acquisition of Anshul Life Sciences for an undisclosed amount.

Shardul Amarchand Mangaldas & Co advised Barentz on this acquisition deal.

The transaction team consisted of by Roopal Kulsrestha (Partner), Neelam Pathak (Partner), Meghna Nachappa (Partner), Aparna R (Associate), Sandra Anil Varkey (Associate), Pranav Bajaj (Associate) and Sidharth Chamarthy (Associate).

Roopal Kulsrestha, Neelam Pathak

AZB & Partners advised Anshul Life Sciences and its promoters on this transaction.

The deal team comprised Senior Partner Vaidhyanadhan Iyer, Partner Sneha Nagvekar, Associates Deepti Narayanan, Priyasha Goyal, Jay Singhee and Meghna Somani.

Barentz is a leading global specialty ingredients solutions provider. With this acquisition, Barentz establishes a leading life science distribution platform in India and reinforces its commitment to providing innovative solutions and technical expertise pan-India.

If you would like your Deals, Columns, Press Releases to be published on Bar & Bench, please fill in the form available here.

Presidential reference on deadlines for Governors: LIVE UPDATES from Supreme Court - Day 5

Mason and Associates is looking to hire Senior Associate/ Principal Associate in Mumbai

Cyril Amarchand Mangaldas acts on cross-border arrangement between Chemours and SRF Ltd

Bombay High Court restrains Shiv Sena leader from making communal remarks against slum developer

From the Bench to the Ballot: Drawing the line in democratic debate

SCROLL FOR NEXT